Everotas 0.25mg Tablet 10 tablets in 1 strip

Last Updated: July 26th, 2023

Everotas 0.25mg Tablet is a product of Intas Pharmaceuticals Ltd

Composition: Everolimus (0.25mg)

Pack of 10 tablet

₹ 430.00

Note: MRP can vary depending up on batch!

*MRP inclusive of all taxes

All Details About Everotas 0.25mg Tablet

Find out detailed description, uses, directions of use, side effects, warnings and precautions, frequently asked questions about Everotas 0.25mg Tablet

Description:

Everotas 0.25mg Tablet is used for the prevention of organ rejection in transplant patients. It regulates the body’s immune response, so the body can accept the new organ. It is also used in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney.

Everotas 0.25mg Tablet must be taken in a dose and duration as per the prescription. It can be taken with or without food but make sure to take it at about the same time every day. An overdose of this medicine may have serious side effects on the body.

The common side effects of this medicine are weakness, sinus inflammation, infection, fever, cough, etc. If any of the side effects persist or bother you, consult the doctor immediately. Inform the doctor immediately if you experience any allergic reactions (rash, shortness of breath, coughing, swelling, etc.). Forever seek medical advice if you have increased thirst or increased frequency of urination, suffer from shortness of breath, cough or fever, or need to receive any vaccination after taking this medication.

Earlier taking this medicine, it is important to consult your doctor if you have any ongoing medication for any underlying disease. Pregnant and breastfeeding women must inform the doctor prior to the initiation of this treatment. During the treatment, your doctor may advise you for some laboratory tests to know the effects of the medicine in the body. It may affect male or female fertility, so consult the doctor if you are planning to have a child.

Uses:

Directions For Use:

Ordinary side effects of Everotas

Weakness
Sinus inflammation
Infection
Fever
Cough
Chubbyigue
Stomatitis (Inflammation of the mouth)
Otitis media (infection of ear)
Diarrhea
Upper respiratory tract infection

Side Effects:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Warning & Precautions:

Alcohol

CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Everotas 0.25mg Tablet. Please consult your doctor.

Pregnancy

CONSULT YOUR DOCTOR

Everotas 0.25mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Breast feeding

CONSULT YOUR DOCTOR

Everotas 0.25mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving

UNSAFE

Everotas 0.25mg Tablet may cause side effects which could affect your ability to drive.
As fatigue is a common side effect with Everotas 0.25mg Tablet and this may affect your ability to drive

Kidney

SAFE IF PRESCRIBED

Everotas 0.25mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Everotas 0.25mg Tablet is recommended.

Liver

CAUTION

Everotas 0.25mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Everotas 0.25mg Tablet may be needed. Please consult your doctor.
Employ of Everotas 0.25mg Tablet is not recommended in patients with severe liver disease.

FAQs:

Q. Is any monitoring required while taking Everotas 0.25mg Tablet?

Regular monitoring is required while you are on Everotas 0.25mg Tablet. The doctor will advise blood tests to see the counts of red blood cells, white blood cells, and platelets since the counts may decrease during treatment with Everotas 0.25mg Tablet. Also, blood tests will be required to check your kidney function, liver function, blood glucose levels, and cholesterol levels.

Q. What should I avoid while taking Everotas 0.25mg Tablet?

You should avoid grapefruit or grapefruit juice while taking Everotas 0.25mg Tablet. This is because taking them together may increase the levels of Everotas 0.25mg Tablet in your blood to harmful levels. Avoid the use of live vaccinations and any possible contact with individuals who have received live vaccinations.

Q. What is the most important information I need to know about Everotas 0.25mg Tablet?

Everotas 0.25mg Tablet can cause serious side effects which include severe allergic reactions, angioedema, and kidney failure which can be severe and can lead to death. It is possible that you may develop an infection or problems related to lung such as breathing problems.

Q. Is Everotas 0.25mg Tablet a chemotherapy?

Everotas 0.25mg Tablet is an anticancer medicine. It belongs to kinase inhibitor class of medicines. It works by reducing the blood supply to the tumor, which slows down the growth and spread of cancer cells.

Q. How is Everotas 0.25mg Tablet administered?

Usually, Everotas 0.25mg Tablet is taken once or twice daily. The medicine should always either be taken with food or always be taken without food. Everotas 0.25mg Tablet should be swallowed whole with water and should not be crushed or chewed.

Q. How long can you take Everotas 0.25mg Tablet?

There is no definite duration of treatment with Everotas 0.25mg Tablet. Everotas 0.25mg Tablet is continued till clinical benefit is seen or unacceptable toxicity or side effects occur.

Q. How will I know that Everotas 0.25mg Tablet is shrinking my brain tumor?

The effect of Everotas 0.25mg Tablet in shrinking the size of tumor can only be checked by getting regular brain scans. It should be done as advised by your doctor and your treatment plan.

Q. Is Everotas 0.25mg Tablet cytotoxic?

Affirmative, Everotas 0.25mg Tablet is cytotoxic against human cancer cells of breast, stomach, prostate, and kidneys (renal cell carcinoma).

Written by:
Dr. T. Sharmila Krishna
M.B.B.S., MD (Biochemistry)

Reviewed by:
Dr. Sureshbabu Yadav
M.B.B.S., DIP.DIAB, F.R.S.H

Disclaimer:

Getomeds primary intention is to ensure that its consumers get information that is reviewed by experts, accurate, and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all of your concerns about any disease or medication. Do not disregard or postpone seeking professional medical advice because of something you read on Getomeds. Our mission is to support, not replace, the doctor-patient relationship.